Open Access
Issue
BioMedicine
Volume 7, Number 2, June 2017
Article Number 10
Number of page(s) 7
DOI https://doi.org/10.1051/bmdcn/2017070203
Published online 14 June 2017
  1. Parkin DM. International variation. Oncogene 2004; 23: 6329–6340. [CrossRef] [PubMed] [Google Scholar]
  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893–2917. [CrossRef] [PubMed] [Google Scholar]
  3. Lee SG, Kim B, Choi J, Kim C, Lee I, Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 2002; 187: 53–60. [CrossRef] [Google Scholar]
  4. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001; 49: 347–53. [CrossRef] [PubMed] [Google Scholar]
  5. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995; 333: 32–41. [CrossRef] [PubMed] [Google Scholar]
  6. Lin CH, Lin CC, Tsai CW, Chang WS, Yang CW, Bau DT. Association of caveolin-1 genotypes with gastric cancer in Taiwan. Anticancer Res. 2014; 34: 2263–2267. [PubMed] [Google Scholar]
  7. Kuo WH, Huang CY, Fu CK, Hsieh YH, Liao CH, Hsu CM, et al. Effects of interleukin-10 polymorphisms and smoking on the risk of gastric cancer in Taiwan. In Vivo. 2014; 28: 967–971. [PubMed] [Google Scholar]
  8. Kuo HW, Huang CY, Fu CK, Liao CH, Hsieh YH, Hsu CM, et al. The significant association of CCND1 genotypes with gastric cancer in Taiwan. Anticancer Res. 2014; 34: 4963–4968. [PubMed] [Google Scholar]
  9. Ji HX, Chang WS, Tsai CW, Wang JY, Huang NK, Lee AS, et al. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan. Anticancer Res. 2015; 35: 4975–4981. [PubMed] [Google Scholar]
  10. Yang MD, Wang HC, Chang WS, Tsai CW, Bau DT. Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan. BMC Cancer. 2011; 11: 174. [CrossRef] [PubMed] [Google Scholar]
  11. Bau DT, Wang HC, Liu CS, Chang CL, Chiang SY, Wang RF, et al. Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan. Chin J Physiol. 2009; 52: 411–418. [CrossRef] [PubMed] [Google Scholar]
  12. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol. 2008; 15: 514–518. [CrossRef] [PubMed] [Google Scholar]
  13. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000; 6: 324–329. [PubMed] [Google Scholar]
  14. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998; 8: 437–441. [CrossRef] [PubMed] [Google Scholar]
  15. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4: 197–250. [CrossRef] [PubMed] [Google Scholar]
  16. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr. 1996; 6: 391–411. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  17. Pulukuri SM, Rao JS. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol. 2008; 32: 757–765. [PubMed] [Google Scholar]
  18. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997; 89: 1260–1270. [CrossRef] [PubMed] [Google Scholar]
  19. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer. 1991; 49: 666–672. [CrossRef] [PubMed] [Google Scholar]
  20. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 1998; 43: 791–797. [CrossRef] [PubMed] [Google Scholar]
  21. Murray GI, Duncan ME, O’Neil P, McKay JA, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol. 1998; 185: 256–261. [CrossRef] [PubMed] [Google Scholar]
  22. Baker EA, Leaper DJ. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. Eur J Cancer. 2003; 39: 981–988. [CrossRef] [PubMed] [Google Scholar]
  23. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998; 58: 5321–5325. [Google Scholar]
  24. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res. 2000; 91: 612–615. [CrossRef] [PubMed] [Google Scholar]
  25. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 1999; 59: 4225–4227. [Google Scholar]
  26. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res. 2001; 7: 2344–2346. [PubMed] [Google Scholar]
  27. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer. 2002; 102: 526–529. [CrossRef] [PubMed] [Google Scholar]
  28. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, et al. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res. 2005; 11: 594–599. [PubMed] [Google Scholar]
  29. Elander N, Soderkvist P, Fransen K. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res. 2006; 26: 791–795. [PubMed] [Google Scholar]
  30. Hettiaratchi A, Hawkins NJ, McKenzie G, Ward RL, Hunt JE, Wakefield D, et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer. 2007; 96: 783–792. [PubMed] [Google Scholar]
  31. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001; 61: 7825–7829. [Google Scholar]
  32. Tsai CW, Chang WS, Gong CL, Shih LC, Chen LY, Lin EY, et al. Contribution of Matrix Metallopeptidase-1 Genotypes, Smoking, Alcohol Drinking and Areca Chewing to Nasopharyngeal Carcinoma Susceptibility. Anticancer Res. 2016; 36: 3335–3340. [PubMed] [Google Scholar]
  33. Sun KT, Tsai CW, Chang WS, Shih LC, Chen LY, Tsai MH, et al. The Contribution of Matrix Metalloproteinase-1 Genotype to Oral Cancer Susceptibility in Taiwan. In Vivo. 2016; 30: 439–444. [PubMed] [Google Scholar]
  34. Matsumura S, Oue N, Kitadai Y, Chayama K, Yoshida K, Yamaguchi Y, et al. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol. 2004; 130: 259–265. [CrossRef] [PubMed] [Google Scholar]
  35. Jin X, Kuang G, Wei LZ, Li Y, Wang R, Guo W, et al. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol. 2005; 11: 2385–2389. [CrossRef] [PubMed] [Google Scholar]
  36. Fang WL, Liang WB, Gao LB, Zhou B, Xiao FL, Zhang L. Genetic polymorphisms in Matrix Metalloproteinases -1 and -7 and susceptibility to gastric cancer: an association study and meta-analysis. Iran J Allergy Asthma Immunol. 2013; 12: 203–210. [PubMed] [Google Scholar]
  37. Devulapalli K, Bhayal AC, Porike SK, Macherla R, Akka J, Nallari P., et al. Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer. Saudi J Gastroenterol. 2014; 20: 309–314. [CrossRef] [Google Scholar]
  38. Dey S, Ghosh N, Saha D, Kesh K, Gupta A, Swarnakar S. Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well1 linked with lower stomach tumor formation in eastern Indian population. PLoS One. 2014; 9: e88040. [PubMed] [Google Scholar]
  39. Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, Nasierowska-Guttmejer A, et al. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer. 1999; 81: 871–876. [CrossRef] [PubMed] [Google Scholar]
  40. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and denocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997; 89: 1277–1284. [CrossRef] [PubMed] [Google Scholar]
  41. Inoue M, Tajima K, Hirose K, Kuroishi T, Gao CM, Kitoh T. Lifestyle and subsite of gastric cancer–joint effect of smoking and drinking habits. Int J Cancer. 1994; 56: 494–499. [CrossRef] [PubMed] [Google Scholar]
  42. Sasazuki S, Sasaki S, Tsugane S. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer. 2002; 101: 560–566. [CrossRef] [PubMed] [Google Scholar]
  43. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997; 72: 565–573. [CrossRef] [PubMed] [Google Scholar]
  44. Moy KA, Fan Y, Wang R, Gao YT, Yu MC, Yuan JM. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2287–2297. [CrossRef] [PubMed] [Google Scholar]
  45. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years’ follow-up of 26, 000 Norwegian men and women. Cancer Causes Control. 1996; 7: 497506. [Google Scholar]
  46. Smyth EC, Capanu M, Janjigian YY, Kelsen DK, Coit D, Strong VE, et al. Tobacco use is associated with increased recurrence and death from gastric cancer. Ann Surg Oncol. 2012; 19: 2088–2094. [CrossRef] [PubMed] [Google Scholar]